Skip to main content

Table 4 Correlation between the change of disease activity markers, disease activity indices, and their components

From: Alteration of matrix metalloproteinase-3 O-glycan structure as a biomarker for disease activity of rheumatoid arthritis

 

ΔACG/Jacalin

ΔMMP-3 (females)

ΔCRP

r 2

p Value

r 2

p Value

r 2

p Value

ΔDAS28-ESR

0.321

0.0017

0.028

0.4114

0.124

0.0564

ΔDAS28-CRP

0.254

0.0062

0.005

0.7334

0.159

0.0292

ΔSDAI

0.245

0.0074

<0.001

0.9379

0.178

0.0203

ΔCDAI

0.241

0.0080

<0.001

0.8952

0.116

0.0651

ΔSJC, 28 joints, n

0.174

0.0271

<0.001

0.9215

0.152

0.0330

ΔTJC, 28 joints, n

0.180

0.0243

0.003

0.8083

0.109

0.0754

ΔPtGA, mm

0.172

0.0280

0.002

0.8092

0.001

0.8884

ΔPGA, mm

0.215

0.0130

0.006

0.7076

0.170

0.0236

ΔCRP, mg/dl

0.055

0.2293

0.023

0.4553

–

–

ΔESR, mm/h

0.468

<0.0001

0.200

0.0218

0.217

0.0094

ΔMMP-3, ng/ml

0.093

0.1143

–

–

0.010

0.6074

ΔHAQ-DI

0.217

0.0125

0.012

0.5896

0.001

0.9000

  1. ACG Agrocybe cylindracea galectin, CDAI Clinical Disease Activity Index, CRP C-reactive protein, DAS28 Disease Activity Score in 28 joints, ESR erythrocyte sedimentation rate, HAQ-DI Health Assessment Questionnaire Disability Index, MMP-3 matrix metalloproteinase-3, PGA Physician Global Assessment, PtGA patient global assessment, SDAI Simplified Disease Activity Index, SJC swollen joint count, TJC tender joint count
  2. Pearson product-moment correlation values are shown